aap Implantate AGLTS:0N5A 34 Capex-to-Operating-Income is 0.00 as of Dec. 2025. GuruFocus rates LTS:0N5A with a GF Score™ of 34/100 and a GF Value™ of €0.93 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 400 Medical Devices & Instruments companies, aap Implantate AG ranks worse than 249999.75% on this metric.
Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.
aap Implantate AG (LTS:0N5A) Capex-to-Operating-Income Explanation
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
aap Implantate AG Capex-to-Operating-Income Related Terms
aap Implantate AG Capex-to-Operating-Income Historical Data
* Premium members only.
The historical data trend for aap Implantate AG's Capex-to-Operating-Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0N5A vs ABT, SYK, MDT: Capex-to-Operating-Income Comparison
For the Medical Devices subindustry, aap Implantate AG's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aap Implantate AG Capex-to-Operating-Income vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where aap Implantate AG's Capex-to-Operating-Income falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Income of 0.00 mean?
aap Implantate AG (LTS:0N5A) has a Capex-to-Operating-Income of 0.00 as of Dec. 2025. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on aap Implantate AG and its competitors. According to the industry distribution chart, aap Implantate AG ranks #999999 out of 400 companies in the Medical Devices & Instruments industry.
Is aap Implantate AG's Capex-to-Operating-Income too high?
aap Implantate AG's current Capex-to-Operating-Income is 0.00. Based on the distribution chart, aap Implantate AG ranks #999999 out of 400 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, aap Implantate AG has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does aap Implantate AG's Capex-to-Operating-Income compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, aap Implantate AG ranks #999999 out of 400 companies for Capex-to-Operating-Income. This places aap Implantate AG in the lower half of its industry. The industry median Capex-to-Operating-Income is 0.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Income for a Medical Devices & Instruments company?
The median Capex-to-Operating-Income among Medical Devices & Instruments companies is 0.47, based on 400 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Income significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Income mean?
A high Capex-to-Operating-Income can signal that a stock is expensive relative to its fundamentals. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on aap Implantate AG and its competitors. For the Medical Devices & Instruments industry, the median Capex-to-Operating-Income is 0.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aap Implantate AG's current Capex-to-Operating-Income is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aap Implantate AG stock overvalued right now?
Based on GuruFocus' analysis, aap Implantate AG (LTS:0N5A) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.93, compared to a current price of €1.67 — trading 79.6% above its estimated fair value. The current Capex-to-Operating-Income is 0.00. aap Implantate AG's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Income calculated?
Capex-to-Operating-Income is calculated from a company's financial statements. For aap Implantate AG (LTS:0N5A), the current Capex-to-Operating-Income is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aap Implantate AG (LTS:0N5A) Overvalued in 2026?
Based on GuruFocus' analysis, aap Implantate AG stock appears to be overvalued.
The current stock price of €1.67 is trading 79.6% above its estimated GF Value™ of €0.93.
GuruFocus considers aap Implantate AG to be Significantly Overvalued.
Key valuation signals for LTS:0N5A:
Capex-to-Operating-Income: 0.00
GF Value™: €0.93 vs. price of €1.67 (79.6% above fair value)
No single metric tells the full story. See the LTS:0N5A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
34GF Score
Get the complete analysis for LTS:0N5A
Capex-to-Operating-Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0N5A has been successfully added to your 
